. Author manuscript; available in PMC: 2016 Jan 1.

Published in final edited form as: Xenotransplantation. 2014 Sep 11;22(1):32–47. doi: 10.1111/xen.12133

Table 1.

Xenograft recipients and immunosuppressive therapy

Group	Recipients	ID	Graft	Survival (days)	Immunosuppressive Therapy^(a)
Organ xenotransplantation (n=7)	Heart (n=3)	B27104 B26704 B16107	GTKO GTKO GTKO/CD46	56 35 26
Organ xenotransplantation (n=7)	Kidney (n=4)	B4207 B4307 B26904 B16307	GTKO/CD46 GTKO/CD46 GTKO GTKO/CD46	9 10 6 10	Anti-CD154mAb + ATG + MMF
Pig artery patch xenotransplantation (n=8)	n=3	B26504 B7506 B4007	GTKO GTKO GTKO	95 14^* 29	None ^(b)
	n=2	B7906 B3707	GTKO GTKO	32 29	Anti-CD154mAb + ATG + MMF
	n=3	B18408 B18608 B18208	GTKO GTKO GTKO	33 29 29	CTLA4-Ig + ATG + MMF

^(a)

For details of dosages, see Supplementary Table 1.

^(b)

Recipients stated to have no IS received cobra venom factor and methylprednisolone only on days −1, 0, and 1

ATG = Anti-thymocyte globulin / MMF = Mycophenolate mofetil

Euthanasia on day 14 due to rupture of patch graft.